Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001511 (
Adhesion
)
5,955
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adhesion
promoting monomers for dental metals, 5-(4-vinylbenzyl)-2-thiobarbituric acid (5VS), 6- (4-vinylbenzyl-n-propyl) amino-
1,3,5-triazine
-2,4-dithione (VBATDT) and 9,10-epithiodecyl methacrylate (EP8MA), were synthesized and surface treatment agents were prepared by dissolving each monomer in ethanol or acetone. Four non-precious and three precious metal adherends treated with each agent were butt-jointed together with MMA-PMMA resins. After 2,000 thermal cyclings in water, tensile bond strengths were measured and the percentage of area of cohesive failure after the tensile test was determined. The bond strengths to precious metal alloys generally increased in the order of 5VS<VBATDT<EP8MA. Bonding durability against water based on overall failure mode analysis was improved in the following order: for precious metal alloys; 5VS<VBATDT< or =EP 8MA, and for non-precious metal alloys; EP8MA, VBATDT<<5VS.
...
PMID:Chemical structures of adhesion promoting monomers for precious metals and their bond strengths to dental metals. 1462 Oct
The ability of some 2-alkyl(aryl)-4,6-dimethoxy-
1,3,5-triazine
derivatives to interfere with production of reactive oxygen species (ROS) by human phagocytes was evaluated in an in-vitro cell model. Superoxide anion (O(2)(-*)) production by human polymorphonuclear cells (PMNs), challenged by the chemotactic agent N-formylmethionyl-leucyl-phenylalanine (FMLP), was inhibited in a dose-dependent manner by all the compounds tested, compounds 3, 4 and 5 being statistically the most active.
Adhesion
of PMNs to vascular endothelial cells (ECs) is a critical step in recruitment and infiltration of leucocytes into tissues during inflammation, and the effects of
1,3,5-triazine
derivatives on PMN adhesion to ECs from the human umbilical vein (HUVEC) were also investigated. Triazines were incubated with PMNs and HUVEC; adhesion was quantitated by computerized micro-imaging fluorescence analysis. The 1,3,5-triazines tested inhibited the adhesion evoked by pro-inflammatory stimuli, such as platelet activating factor (PAF), FMLP, phorbol myristate acetate (PMA), tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta(IL-1beta) in a dose-response manner over the concentration range 10(-9) to 10(-4)M, compounds 5 and 6 being the most active. Both of these compounds inhibited PMN adhesion to HUVEC, even when endothelial or PMN stimuli were used. Indeed, when both cell populations were activated contemporarily, the anti-adhesive effect was enhanced. The study suggests that 2-aryl-4,6-dimethoxy-1,3,5-triazines deserve further evaluation as anti-inflammatory agents.
...
PMID:Evaluation of in-vitro anti-inflammatory activity of some 2-alkyl-4,6-dimethoxy-1,3,5-triazines. 1645 50